Notice2022-07247
Advisory Committee to the Director (ACD), Centers for Disease Control and Prevention (CDC)
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
April 6, 2022
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Abstract
In accordance with the Federal Advisory Committee Act, the CDC announces the following meeting for the Advisory Committee to the Director, Centers for Disease Control and Prevention (ACD, CDC). This meeting is open to the public. Time will be available for public comment. The meeting will be webcast live via the World Wide Web.
Full Text
<html>
<head>
<title>Federal Register, Volume 87 Issue 66 (Wednesday, April 6, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 66 (Wednesday, April 6, 2022)]
[Notices]
[Pages 19938-19939]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-07247]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[Docket No. CDC-2022-0046]
Advisory Committee to the Director (ACD), Centers for Disease
Control and Prevention (CDC)
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting and request for comment.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC
announces the following meeting for the Advisory Committee to the
Director, Centers for Disease Control and Prevention (ACD, CDC). This
meeting is open to the public. Time will be available for public
comment. The meeting will be webcast live via the World Wide Web.
DATES: The meeting will be held on May 3, 2022, from 11:00 a.m. to 4:00
p.m., EDT (times subject to change). The public may submit written
comments from April 6, 2022 through April 28, 2022.
ADDRESSES: You may submit comments identified by Docket No. CDC-2022-
0046 by any of the following methods:
<bullet> Federal eRulemaking Portal: <a href="https://www.regulations.gov">https://www.regulations.gov</a>.
Follow the instructions for submitting comments.
<bullet> Mail: Kerry Caudwell, MPA, Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS H21-10, Atlanta, Georgia 30329-
4027. Attn: Docket No. CDC-2022-0046.
Instructions: All submissions received must include the Agency name
and Docket Number. All relevant comments received in conformance with
the <a href="https://www.regulations.gov">https://www.regulations.gov</a> suitability policy will be posted
without change to <a href="https://www.regulations.gov">https://www.regulations.gov</a>, including any personal
information provided. For access to the docket to read background
documents or comments received, go to <a href="https://www.regulations.gov">https://www.regulations.gov</a>.
Written public comments submitted up to 72 hours prior to the ACD
meeting will be provided to ACD members before the meeting.
Written comments received in advance of the meeting will be
included in the official record of the meeting.
FOR FURTHER INFORMATION CONTACT: Kerry Caudwell, MPA, Centers for
Disease Control and Prevention, Office of the Chief of Staff, 1600
Clifton Road NE, MS H21-10, Atlanta, Georgia 30329-4027, Telephone:
(404) 639-7000; Email Address: <a href="/cdn-cgi/l/email-protection#edacaea9849f888e99829fad8e898ec38a829b"><span class="__cf_email__" data-cfemail="d9989a9db0abbcbaadb6ab99babdbaf7beb6af">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION:
Purpose: The Advisory Committee to the Director (ACD), CDC, shall
advise the Secretary, HHS, and the Director, CDC, on policy and broad
strategies that will enable CDC to fulfill its mission of protecting
health through health promotion, prevention, and preparedness. The
committee recommends ways to prioritize CDC's activities, improve
results, and address health disparities. It also provides guidance to
help CDC work more effectively with its various private and public
sector constituents to make health protection a practical reality.
Matters to be Considered: The agenda will include discussions
regarding CDC's current and future work in the following topic areas:
(1) Data modernization; (2) laboratory quality; and (3) health equity.
The Advisory Committee to the Director (ACD) will consider the
formation of working groups for each of the first two topics and hear a
report from the existing health equity working group on the third
topic. Agenda items are subject to change as priorities dictate.
Public Participation
Interested persons or organizations are invited to participate by
submitting written views, recommendations, and data. Please note that
comments received, including attachments and other supporting
materials, are part of the public record and are subject to public
disclosure. Comments will be
[[Page 19939]]
posted on <a href="https://www.regulations.gov">https://www.regulations.gov</a>. Therefore, do not include any
information in your comment or supporting materials that you consider
confidential or inappropriate for public disclosure. If you include
your name, contact information, or other information that identifies
you in the body of your comments, that information will be on public
display. CDC will review all submissions and may choose to redact, or
withhold, submissions containing private or proprietary information
such as Social Security numbers, medical information, inappropriate
language, or duplicate/near duplicate examples of a mass-mail campaign.
CDC will carefully consider all comments submitted into the docket.
Written Public Comment: The docket will be opened to receive
written comments on April 6, 2022 through April 28, 2022.
Oral Public Comment: This meeting will include time for members of
the public to make an oral comment. Oral public comment will occur
before any scheduled votes. Priority will be given to individuals who
submit a request to make an oral public comment before the meeting
according to the procedures below.
Procedure for Oral Public Comment: All persons interested in making
an oral public comment at the May 3, 2022, ACD meeting must submit a
request by visiting <a href="https://www.cdc.gov/about/advisory-committee-director/">https://www.cdc.gov/about/advisory-committee-director/</a> no later than 11:59 p.m., EDT, April 22, 2022, according to
the instructions provided.
If the number of persons requesting to speak is greater than can be
reasonably accommodated during the scheduled time, CDC will conduct a
lottery to determine the speakers for the scheduled public comment
session. CDC staff will notify individuals regarding their request to
speak by email by April 26, 2022. To accommodate the significant
interest in participation in the oral public comment session of ACD
meetings, each speaker will be limited to 2 minutes, and each speaker
may only speak once per meeting.
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2022-07247 Filed 4-5-22; 8:45 am]
BILLING CODE 4163-18-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on April 6, 2022.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.